Resultado da Busca
We collect and analyse data from most countries around the world to make sure appropriate standards and systems are in place to prevent unnecessary harm to patients. Harmonising medicinal product definitions for safer medicines everywhere.
- WHODrug Portfolio
A safer medicine life cycle. With its standardised data,...
- Education & Training
Your knowledge centre for medicines safety. Together with...
- VigiLyze
VigiLyze supports the entire signal detection and management...
- WHODrug Subscription
How to subscribe. 1. Please click on the enquiry button in...
- VigiBase Services
VigiBase is the richest source of pharmacovigilance data in...
- WHODrug User Area
We can't sign you in. Your browser is currently set to block...
- WHODrug News
We make your experience more interactive. Simply follow the...
- VigiFlow for AEFI
Key benefits. Based on the standard reporting form for AEFI,...
- WHODrug Portfolio
26 de jun. de 2024 · Learn about medicines safety and pharmacovigilance systems and processes with UMC's self-paced online courses. Suitable for staff from national or regional pharmacovigilance centres and other professionals working in the public sector and academia.
Uppsala Monitoring Centre offers online courses and resources to support the safer use of medicines and vaccines. Learn about signal detection, causality assessment, medication errors and more.
Uppsala Monitoring Centre is the WHO Collaborating Centre for International Drug Monitoring, based in Sweden. It collects and analyses data on the benefits, harms and risks of drugs and other substances used in medicine.
UMC is an independent foundation that supports the WHO Programme for International Drug Monitoring and advances the science of pharmacovigilance globally. The website provides information about UMC's activities, products, services, publications, and Vaccine Safety Net portal.
The Uppsala Monitoring Centre (UMC) was the first WHO Collaborating Centre to be established for pharmacovigilance when, in 1978, the scientific and technical responsibility of the WHO Programme for International Drug Monitoring was transferred to Sweden.
The UMC is an independent foundation that works internationally for patient safety and the safe and effective use of medicines. It provides various services and is involved in scientific research based on an agreement with the World Health Organization and Sweden.